Clinical evaluation of Ayurvedic management in Allergic Rhinitis-A Randomized Controlled trial

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年6月26日

试验速览

暂无简介。

•1.Patients either sex ages between 18 to 65 years.
•2.IAR or PER (as per the internationally recognized diagnostic standard ARIA), diagnosed by medical history . (Annexure I)
•3.Able and willing to participate and provide signed informed consent.

•1.History of chronic nasal or upper respiratory tract symptoms or disorders other than allergic rhinitis.
•2.History of non allergic rhinitis, chronic sinusitis or serve bronchial asthma.
•3.Patients with nasal anatomical defects (grossly deviated nasal septum).
•4.Patients with Nasal Polyposis.
•5.Patients with associated tonsillitis or airway obstructions (adenoids).
•6.Has a nasal condition likely to affect the outcome of the study.
•7.Any treatment of H1 antihistamine medication, Non-steroidal analgesics. Corticosteroids Nasal drops, Leukotriene antagonists, Nasal vasoconstrictors.
•8. Patients with a history of surgical procedure on the nose like Septoplasty/Submucous resection, Inferior turbinate reduction, Endoscopic sinus surgery.
•9.Pregnant ladies and Lactating mothers.
•10.Patients suffering from any debilitating chronic disease like tuberculosis, Uncontrolled Diabetes mellitus
•11.Any unstable cardio-vascular diseases
•12.Patients with evidence of malignancy.
•13.Patients with concurrent hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT) > 2 times upper normal limit or Renal Disorders (defined as S. creatinine > upper limit of Lab. value), Pulmonary Dysfunction (Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD])
•14.Patient has an acute mental disorder
•15.Patients who are currently participating in any other clinical trial.

发起方